Why the study?
Nonadherence to antihypertensive drugs is a major barrier to effectively managing blood pressure, motivating an assessment of hypertensive patients' attitudes toward antihypertensive medication use.
What are the attitudes and treatment satisfaction levels regarding antihypertensive medications among hypertensive patients in a low-to-middle-income country?
What are the attitudes and treatment satisfaction levels regarding antihypertensive medications among hypertensive patients in a low-to-middle-income country?
Hypertensive patients in this setting reported high satisfaction and positive attitudes toward their medications, though longer disease duration and higher BMI were associated with more negative attitudes.
Answers are grounded in this paper and cite their sources.
Positive attitudes and high satisfaction with antihypertensives may support adherence; cross-sectional data leaves open whether interventions improve control.
Background One major barrier to effectively managing blood pressure in hypertensive patients is nonadherence to antihypertensive drugs. Therefore, the primary goal of the current study was to assess hypertensives’ attitudes toward the use of antihypertensive drugs. Methods This cross-sectional study’s methodological instrument was a questionnaire. The locations used for the study were the primary healthcare facilities under the Ministry of Health. In addition to clinical and demographic information, the questionnaire included the Arabic versions of the Drug Attitude Inventory (DAI-10) and the Treatment Satisfaction Questionnaire for Medication (TSQM). Results In this study, 356 patients with hypertension were included. More than half of the patients (57.6%, n = 205) were on amlodipine, whereas 117 (32.9%) used valsartan. The vast majority of the patients (95.2%) believed that they benefited from their antihypertensive drugs, with the benefits outweighing the drawbacks. The majority were satisfied with the effectiveness of their antihypertensive medications, 59.6% were very satisfied, and 23.3% were satisfied with the ability of antihypertensive medications to treat the disease condition. The DAI-10 score was negatively associated with the time since diagnosis (p = 0.004), the presence of documented food or drug allergies (p < 0.001), and the body mass index (BMI) (p = 0.004). In contrast, DAI-10 scores were positively associated with the perceived effectiveness of antihypertensive medications (p = 0.010), convenience (p = 0.040), and global satisfaction scores (p < 0.001). The perceived effectiveness score was significantly associated with side effect scores (p = 0.002), convenience (p < 0.001), and global satisfaction (p < 0.001). Global satisfaction was negatively associated with time since diagnosis (p = 0.008) and positively associated with the DAI-10 score (p < 0.001), effectiveness (p < 0.001), and side effects (p < 0.001). Conclusions This study revealed that attitudes toward and levels of satisfaction with antihypertensives were positive and high among hypertensive patients. This is specifically related to the effectiveness and convenience of antihypertensives. The time since the diagnosis of hypertension, records of documented allergies, and patient BMI play significant roles as predictive factors for the development of negative attitudes and lack of patient satisfaction. Measures should therefore be put in place to encourage positive attitudes and satisfaction among hypertensive individuals.
No takes yet. Share an insight, caveat, or question.
Yaseen et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: